Vancomycin
Vancocin, Vancomycin Aptapharma, Vancomycin Dr. Eberth, Vancomycin Enterocaps · ATC code J01XA01
Also known as: Vankomisin · Brand names: Vancocin, Vancomycin Aptapharma, Vancomycin Dr. Eberth, Vancomycin Enterocaps, Vancomycin Hikma, Vancomycin Mip, Vancomycin Noridem, Vanco-Saar, Vancomycin "lederle", Vancomycin Bendalis Gmbh, Vancomycin Kabi, Vancomycin Lederle, Vancomycin Mip Pharma, Vancomycinhydrochlorid Cp, Vancosan …
- Key facts
- Active substance
- Vancomycin
- Drug class
- Glycopeptide antibiotic
- ATC code
- J01XA01
- Authorisation
- authorised nationally; no central EU authorisation
- Information as of
- 2026-10-27
Key facts
Vancomycin is a glycopeptide antibiotic. The oral solution is used for enterocolitis caused by Staphylococcus aureus and pseudomembranous colitis caused by C. difficile.
What it is used for
- Enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains)
- Antibiotic-associated pseudomembranous colitis caused by C. difficile
- Must be given orally for these infections; oral vancomycin is not effective for other infections
Dosing
- Adults: usually 500 mg to 2 g daily by mouth in 3 or 4 divided doses for 7 to 10 days
- Children: 40 mg/kg daily in 3 or 4 divided doses for 7 to 10 days; total daily dose not to exceed 2 g
Contraindications
- Known hypersensitivity to vancomycin
Important warnings
- Nephrotoxicity, also after oral therapy, during or after treatment; risk higher in patients over 65 years, whose renal function should be monitored during and after treatment
- Ototoxicity, transient or permanent, mostly with excessive intravenous doses, underlying hearing loss or concomitant ototoxic drugs
- Severe dermatologic reactions (TEN, SJS, DRESS, AGEP, linear IgA bullous dermatosis)
- Use only for infections proven or strongly suspected to be caused by susceptible bacteria
Side effects
- Nephrotoxicity in 5% of subjects (6% over 65 years, 3% aged 65 and younger), typically within one week after completing treatment
- More frequent in older patients: hypokalemia, urinary tract infection, peripheral edema, insomnia, constipation, anemia, vomiting, hypotension
- Most common reasons for discontinuation: C. difficile colitis, nausea, vomiting
- Rarely vertigo, dizziness, tinnitus; hearing loss reported with intravenous use
Interactions
- Other ototoxic drugs such as aminoglycosides: increased risk of ototoxicity
Summary of the official product information, written with AI (Claude, Anthropic) on 2026-10-28. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Patient information (US)
This product has no separate US patient information.
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
Austria
- VancocinAstro-Pharma Gmbh · 1 register entry
- Vancomycin AptapharmaApta Medica Internacional D.O.O. · 1 register entry
- Vancomycin Dr. EberthDr. Friedrich Eberth Arzneimittel Gmbh · 2 register entries
- Vancomycin EnterocapsEsteve Pharmaceuticals Gmbh · 2 register entries
- Vancomycin HikmaHikma Farmacêutica (Portugal), S.A. · 1 register entry
- Vancomycin MipMip Pharma Austria Gmbh · 1 register entry
- Vancomycin NoridemNoridem Enterprises Ltd · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Germany
- Vanco-SaarMip Pharma Gmbh · 1 register entry
- Vancomycin "lederle"Esteve Pharmaceuticals Gmbh · 1 register entry
- Vancomycin Bendalis GmbhBendalis Gmbh · 1 register entry
- Vancomycin Dr. EberthDr. Friedrich Eberth Arzneimittel Gmbh · 2 register entries
- Vancomycin EnterocapsEsteve Pharmaceuticals Gmbh · 1 register entry
- Vancomycin KabiFresenius Kabi Deutschland Gmbh · 1 register entry
- Vancomycin LederleEsteve Pharmaceuticals Gmbh · 1 register entry
- Vancomycin Mip PharmaMip Pharma Gmbh · 1 register entry
- Vancomycin NoridemNoridem Enterprises Ltd · 1 register entry
- Vancomycinhydrochlorid CpHikma Farmacêutica (Portugal), S.A. · 2 register entries
- VancosanCnp Pharma Gmbh, Mip Pharma Gmbh · 2 register entries
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Turkey
- Anko-LGENSENTA İLAÇ SANAYİ VE TİC. A.Ş. · 2 register entries
- EdicinSANDOZ İLAÇ SAN. VE TİC. A.Ş. · 6 register entries
- VamocozinSABA İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
- VamycinPHARMADA İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
- VancomaxVEM İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
- VancotekKOÇAK FARMA İLAÇ VE KİMYA SAN. A.Ş. · 2 register entries
- VankocentCENTURİON İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
- Vankomisin Hcl DblORNA İLAÇ TEKSTİL KİMYEVİ MAD. SAN. VE DIŞ TİC. LTD. ŞTİ. · 2 register entries
- VankomylWORLD MEDICINE İLAÇ SAN. VE TİC. A.Ş. · 6 register entries
- VankopolPOLİFARMA İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
- VankuraisAROMA İLAÇ SAN. LTD. ŞTİ. · 2 register entries
- VanofeksinWORLD MEDICINE İLAÇ SAN. VE TİC. A.Ş. · 6 register entries
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16
USA
- TyzavanHikma Pharmaceuticals USA Inc. · 1 register entry
- VancocinANI Pharmaceuticals, Inc. · 1 register entry
Source: U.S. FDA – Drug labels (openFDA/DailyMed), as of 2026-10-28
Brand names in 27 more European countries
- Belgium
- Vancomycine Fresenius Kabi, Vancomycine Sandoz, Vancomycine Viatris
- Bulgaria
- Vancocin Cp, Ванко-Вм, Ванкомицин Mip, Ванкомицин Алуфарма, Ванкомицин Аптафарма, Ванкомицин Ромфарм
- Croatia
- Edicin, Vancomicin Viatris, Vankomicin Aptapharma, Vankomicin Hameln, Vankomicin Mip, Vankomicin Pharmas, Vankomicin Viatris
- Cyprus
- Vanco, Vancomycin Noridem, Vancomycin Viatris, Vanovan
- Czechia
- Cedepos, Edicin, Vancomycin Aptapharma, Vancomycin Hameln, Vancomycin Kabi, Vancomycin Mip Pharma, Vancomycin Mylan, Vancomycin Noridem, Vancomycin Olikla, Vancomycin Sanexcel, Vancomycin Viatris
- Denmark
- Bactocin, Vancocin, Vancomycin "sandoz", Vancomycin Fresenius Kabi, Vancomycin Hameln, Vancomycin Noridem, Vancomycin Orion, Vancomycin Reig Jofre, Vancomycin Strides, Vancomycin Viatris
- Estonia
- Vancomycin Kabi, Vancosan
- Finland
- Vancomycin Bioglan, Vancomycin Hameln, Vancomycin Mip Pharma, Vancomycin Noridem, Vancomycin Orion, Vancomycin Strides, Vancomycin Xellia, Vancosan
- France
- Vancomycine Hikma, Vancomycine Kabi, Vancomycine Mip, Vancomycine Noridem, Vancomycine Reig Jofre, Vancomycine Sandoz, Vancomycine Strides, Vancomycine Viatris
- Greece
- Lyovanco, Vancomycin Noridem, Vancomycin Norma, Vancomycin Viatris, Vancomycin Vocate, Vancoten, Vondem, Voxin
- Hungary
- Vancocin, Vancomycin Aptapharma, Vancomycin-Human Teva, Vancomycin Kabi, Vancomycin Rompharm, Vancomycin Strides
- Iceland
- Vancomycin Fresenius Kabi, Vancomycin Hameln, Vancomycin Mip, Vancomycin Orion, Vancomycin Xellia
- Ireland
- Vancocin, Vancomycin
- Italy
- Levovanox, Maxivanil, Vancocina A.P., Vancomicina Hikma, Vancomicina Mylan, Vancomicina Reig Jofre, Vancotex, Zengac
- Latvia
- Vancomycin Kabi, Vancosan
- Lithuania
- Vancomycin Ibe, Vancomycin Kabi, Vancosan
- Luxembourg
- Vancomycin Enterocaps, Vancomycine
- Malta
- Cedepos, Vancomycin Aptapharma, Voxin
- Netherlands
- Vancocin Cp, Vancomycine Fresenius Kabi, Vancomycine Hikma, Vancomycine Mip, Vancomycine Noridem, Vancomycine Sandoz, Vancomycine Strides
- Norway
- Vancomycin Fresenius Kabi, Vancomycin Hameln, Vancomycin Mip, Vancomycin Noridem, Vancomycin Orion, Vancomycin Reig Jofre, Vancomycin Strides, Vancomycin Viatris, Vancomycin Xellia
- Poland
- Edicin, Vancomicina Reig Jofre, Vancomycin Aptapharma, Vancomycin Kabi, Vancomycin Mip, Vancomycin Pharmline, Vancomycin Sanexcel
- Portugal
- Vancomicina Azevedos, Vancomicina Generis, Vancomicina Gufic, Vancomicina Hikma, Vancomicina Kabi, Vancomicina Noridem, Vancomicina Normon, Vancomicina Quimedical, Vancomicina Reig Jofre, Vangrotin
- Romania
- Cedepos, Vancomicina Atb, Vancomicina Kabi, Vancomicină Aptapharma, Vancomicină Mip, Vancomicină Rompharm, Vancomicină Viatris
- Slovakia
- Cedepos, Edicin, Vancomycin Aptapharma, Vancomycin Hameln, Vancomycin Kabi, Vancomycin Mip, Vancomycin Noridem, Vancomycin Olikla, Vancomycin Sanexcel, Vancomycin Viatris
- Slovenia
- Edicin, Vancomycin Viatris, Vankomicin Apta, Vankomicin Aptapharma, Vankomicin Hameln, Vankomicin Kabi, Vankomicin Lek
- Spain
- Vancomicina Mip, Vancomicina Noridem, Vancomicina Normon, Vancomicina Sala, Vangozyr
- Sweden
- Vancocin, Vancomycin Bioglan, Vancomycin Hameln, Vancomycin Mip, Vancomycin Noridem, Vancomycin Orion Pharma, Vancomycin Strides, Vancomycin Viatris, Vancomycin Xellia
EMA – Article 57 product data (EU/EEA), 2026-10-28
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Other substances in the same group
Related calculators
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- U.S. Food and Drug Administration. Vancomycin Hydrochloride (ANI Pharmaceuticals, Inc.) – Prescribing Information, 2026-03-02. DailyMed (NLM), 2026-10-27. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=27d06545-1af0-4dcd-926d-58d4a9492ec3
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
- U.S. FDA – Drug labels (openFDA/DailyMed), 2026-10-28. https://dailymed.nlm.nih.gov/dailymed/
- Wikidata (CC0): ATC J01XA.
Editorial: Medelix editorial team · last updated 2026-10-27 · How these pages are made · Report an error
Source: U.S. Food and Drug Administration (FDA), prescribing information, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.